Connect with us

Hi, what are you looking for?

THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Not Sure

Not Sure

The FDA Proposes New Rules for Opioids to Make Drugs Less Addictive

opioid drugs
opioid drugs

The Food and Drug Administration (FDA) is looking into changing the rules for the manufacturing of opioids by making the drugs less addictive.

The new proposal states that the drug manufacturers would have to report if their products have “any characteristics that would mitigate the risks of overdose, abuse, or the development of addiction.”

The FDA also said: “Companies should also indicate whether their drugs have novel or greater risks compared to other opioids on the market and also note the public health implications of their products in terms of risks to non-patients, including members of the patient’s household, visiting relatives, friends, and others.”

According to the data from the U.S. Centers for Disease Control and Prevention, 47,000 people died from a drug overdose in 2017, with approximately 130 individuals overdosing every day. The Trump administration considers this to be a significant problem and has promised to crack down on illicit drug use.

Acting FDA Commissioner, Ned Sharpless, made a statement: “Addressing the crisis of opioid addiction is an issue of great concern for our nation and remains a top public health priority for the FDA. The agency continues to take new steps to confront this crisis while also paying careful attention to the needs of patients in accessing appropriate pain management.”

The FDA has admitted that opioids are challenging since the drugs help patients with pain management, but that they can also cause immense harm if misused or abused.

Related: Demi Lovato Wakes Up After Drug Over Dose

Comment Template

You May Also Like


On Monday, contract drugmaker Catalent Inc. (CTLT.N) said it expected to “significantly” lower its 2023 sales and core profit expectations and delay its third-quarter...


On Monday, Japan’s Astellas Pharma (4503.T) announced its largest purchase, buying U.S. pharmaceutical Iveric Bio Inc. for $5.9 billion to gain access to ophthalmic...

Breaking News

Pfizer’s RSV shot access commitment faces challenges. Global health authorities told Reuters that Pfizer Inc (PFE.N) has vowed to provide crucial new medicines faster...


GSK (GSK.L) will buy Bellus Health Inc. (BLU.TO) for $2 billion in cash as it bets on respiratory medicines. GSK investors worry about whether...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.